Yes I would have no problems with that SP.
We expecting US revenue by mid 2019 all going to plan for aGVHD , it still remains a possibility that this could be sooner but would require the support of US regulatory bodies.
Too add to this revenue we are expecting the 2b trial for CHF with LVAD read out very soon. Could be a deal with outside party or possibly we go to the FDA with two products. Many of the required checks could be done simultaneously and would save someone a fortune.
Best to all.
Yes I would have no problems with that SP. We expecting US...
-
- There are more pages in this discussion • 1,912 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.010(0.84%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.18 | $1.302M | 1.095M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 26990 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 245379 | 29 |
View Market Depth
| Last trade - 10.47am 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |